Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI
The Thoracic and Cardiovascular Surgeon · 01.03.2023 · 71 (02) · 084-093
DOI: 10.1055/s-0041-1730972 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.03.2023. Verfasst von Lukasz Kmiec und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, University Medical Center Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Vascular Closure Devices, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
The MANTA vascular closure device (VCD) is a novel collagen plug-based VCD for large bore arteriotomies. The current literature regarding complication rates of this device is quite variable and mostly limited to relatively small case series.
Methods
This study is retrospective analysis of the MANTA VCD-related main access site complications according to Valve Academic Research Consortium-2 (VARC-2) criteria during the hospital stay. Particular attention was paid to the detailed analysis of multislice computed tomography with regard to the anatomy of the access vessel and the puncture site itself.
Results
A total of 524 patients underwent transfemoral transcatheter aortic valve implantation (TF TAVI) including the use of the MANTA device (18F) for percutaneous vascular closure. A group of 22 patients was excluded from the study due to incomplete imaging data. During the study period, we observed 28 major (5.6%) and five minor (1.0%) MANTA device-related vascular complications. There was no patient death related to these adverse events. Female gender, vessel angulation at the puncture site, and at least moderate calcification of the dorsal vessel segment were identified as independent predictors for major complications.
Conclusions
The MANTA device is a feasible option for vascular closure of large bore arteriotomies in patients undergoing TF TAVI or other percutaneous transfemoral interventions. Furthermore, we have identified novel predictors for device failure/complications that should be taken into account for selection of the appropriate closure device. To our knowledge, this report is one of the largest case series analyzing the use of the MANTA VCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, University Medical Center Regensburg, Regensburg, Germany.
- Department of Internal Medicine II, University Medical Center Regensburg, Regensburg, Germany.
ORCID-Profile: Lukasz Kmiec
Zitieren
APA
Kmiec, L., Zerdzitzki, M., Schmid, C., Debl, K., Sossalla, S., Hilker, M., & Holzamer, A. (2023). Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI. The Thoracic and Cardiovascular Surgeon, 71(02), 084-093. https://doi.org/10.1055/s-0041-1730972
Vancouver
Kmiec L, Zerdzitzki M, Schmid C, Debl K, Sossalla S, Hilker M, et al. Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI. The Thoracic and Cardiovascular Surgeon. 2023;71(02):084-093. doi:10.1055/s-0041-1730972
BibTeX
@article{Kmiec2023,
author = {Kmiec, Lukasz and Zerdzitzki, Matthaeus and Schmid, Christof and Debl, Kurt and Sossalla, Samuel and Hilker, Michael and Holzamer, Andreas},
title = {Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2023},
volume = {71},
number = {02},
pages = {084--093},
doi = {10.1055/s-0041-1730972}
}
EUVIMED